Trypanosoma cruzi, the causative agent of Chagas' disease, is a blood and tissue parasite whose invasive trypomastigote stage must attach to and enter mammalian cells to complete its intracellular development and disseminate infection. To accomplish this goal, it must first crossthe meshwork of the extracellular matrix (ECM) inwhich host cells are interacting. Trypomastigotes possess receptors for host ECM proteins on their surfaces. Recent evidence has shown that the parasite uses released trans-sialidase and mucin molecules to aid in its attachment and entry into cells. The long-term goal is to understand the molecular mechanisms that allow T. cruzi to infect mammalian cells, so that specific molecular intervention strategies can be developed against T. cruzi infection. This application's objective is to understand how T. cruzi uses the extracellular matrix in order to establish infectionin mammalian cells. My preliminary studies using high density cDNA microarray technology and real-time PCR indicatesthat T. cruzi trypomastigotes release surface molecules to up-regulate gone transcription of laminin and thrombospondin in human coronary artery smooth muscle cells. Furthermore, incubation of these cells with trypanosome released molecules increases infection significantly. Based on these findings, the hypothesis of this application is that released surface molecules of invasive forms of T. cruzi target host cells to up-regulate the expression of laminin and thrombospondin in order to recruittrypomastigotes to enhance infection. In order to test this hypothesis the following specific aims are proposed (i) to determine the extent to which RNA interference (RNAi) of laminin I and thrombospondin I reduces T. cruzi infection of hostcells, and (ii) to determine the ability of antibodies to laminin I and thrombospondin I to reduce T. cruzi infection in cells exposed to trypomastigote released molecules.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31AI056667-02
Application #
6816281
Study Section
Special Emphasis Panel (ZRG1-MBC-1 (29))
Program Officer
Hernandez, Milton J
Project Start
2003-09-01
Project End
2005-06-30
Budget Start
2004-09-01
Budget End
2005-06-30
Support Year
2
Fiscal Year
2004
Total Cost
$35,131
Indirect Cost
Name
Meharry Medical College
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
041438185
City
Nashville
State
TN
Country
United States
Zip Code
37208
Madison, M Nia; Kleshchenko, Yuliya Y; Nde, Pius N et al. (2007) Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction. Infect Immun 75:4780-91
Simmons, Kaneatra J; Nde, Pius N; Kleshchenko, Yuliya Y et al. (2006) Stable RNA interference of host thrombospondin-1 blocks Trypanosoma cruzi infection. FEBS Lett 580:2365-70
Augustine, Swinburne A J; Kleshchenko, Yuliya Y; Nde, Pius N et al. (2006) Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection. Infect Immun 74:3922-9
Nde, Pius N; Simmons, Kaneatra J; Kleshchenko, Yuliya Y et al. (2006) Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection. Infect Immun 74:1643-8